Effects of Side Chain and Peptide Bond Modifications on the Targeting Properties of Stabilized Minigastrin Analogs
Different attempts have been made in the past two decades to develop radiolabeled peptide conjugates with enhanced pharmacokinetic properties in order to improve the application for tumor imaging and peptide receptor radionuclide therapy (PRRT), which targets the cholecystokinin-2 receptor (CCK2R)....
Main Authors: | Taraneh Sadat Zavvar, Anton Amadeus Hörmann, Maximilian Klingler, Dominik Summer, Christine Rangger, Laurence Desrues, Hélène Castel, Pierrick Gandolfo, Elisabeth von Guggenberg |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-02-01
|
Series: | Pharmaceuticals |
Subjects: | |
Online Access: | https://www.mdpi.com/1424-8247/16/2/278 |
Similar Items
-
Cholecystokinin-2 Receptor Targeting with Novel C-terminally Stabilized HYNIC-Minigastrin Analogs Radiolabeled with Technetium-99m
by: Maximilian Klingler, et al.
Published: (2019-01-01) -
Automated Synthesis of <sup>68</sup>Ga-Labeled DOTA-MGS8 and Preclinical Characterization of Cholecystokinin-2 Receptor Targeting
by: Anton Amadeus Hörmann, et al.
Published: (2022-03-01) -
Radiopharmaceutical Formulation and Preclinical Testing of <sup>68</sup>Ga-Labeled DOTA-MGS5 for the Regulatory Approval of a First Exploratory Clinical Trial
by: Anton A. Hörmann, et al.
Published: (2021-06-01) -
Initial In Vitro and In Vivo Evaluation of a Novel CCK2R Targeting Peptide Analog Labeled with Lutetium-177
by: Anton Amadeus Hörmann, et al.
Published: (2020-10-01) -
Investigation of the structure-activity relationship at the N-terminal part of minigastrin analogs
by: Nadine Holzleitner, et al.
Published: (2023-07-01)